Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Aadi Bioscience, Inc. (AADI) is a stock that can certainly grab the attention of ...
On Thursday, Aadi Bioscience, Inc. (NASDAQ:AADI) entered into an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical antibody-drug ...
LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Aadi Bioscience, Inc. (AADI) today announced it has entered into an exclusive license agreement for development and global commercialization of a three-asset ...
Aadi Bioscience is a biotech company focused on a nanoliposomal encapsulation of the mTOR inhibitor sirolimus. Their drug, nab-sirolimus, has been approved for the treatment of PEComa, a rare soft ...
Tuesday, Aadi Bioscience Inc. (NASDAQ:AADI) announced it will halt the registration-intended PRECISION1 trial of nab-sirolimus in patients with solid tumors harboring TSC1 or TSC2 inactivating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results